COVID-19 Linked to Chronic Fatigue Syndrome

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 21, 2025.

By Dennis Thompson HealthDay Reporter

TUESDAY, Jan. 21, 2025 -- COVID-19 appears to increase a person’s risk of developing chronic fatigue syndrome.

People who’ve caught COVID are nearly five times more likely to develop chronic fatigue syndrome, according to results recently published in the Journal of General Internal Medicine.

This could explain why new cases of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are 15 times higher now than they were prior to the pandemic, researchers said.

“Our results provide evidence that the rate and risk of developing ME/CFS following SARS-CoV-2 infection is significantly increased,” a team led by Suzanne Vernon, research director of the Bateman Home Center in Salt Lake City, concluded.

People with ME/CFS suffer from constant fatigue, and become even more tired after exerting themselves in activities as common as running errands, attending school events, getting work done or even showering, the U.S. Centers for Disease Control and Prevention (CDC) says.

They also might suffer from sleep problems, dizziness and difficulty with memory or thinking.

Many of these symptoms also are found in people suffering from long COVID, leading researchers to suspect a possible link.

It’s also known that ME/CFS can be triggered by other infections like Epstein/Barr virus, researchers noted.

For this study, researchers drew upon data gathered as part of a study on the long-term health effects of COVID.

Researchers tracked nearly 12,000 people who’d been infected with COVID and compared their health to more than 1,400 people who hadn’t come down with the coronavirus.

Results show that about 4.5% of people who’ve been infected with COVID develop chronic fatigue syndrome, compared with 0.6% who haven’t been infected.

Post-exertional malaise, dizziness when standing and cognitive impairment were the most common ME/CFS symptoms reported by COVID patients.

More study is needed to understand why some COVID patients are more likely to develop ME/CFS following infection than others, researchers concluded.

Sources

  • National Institutes of Health, news release, Jan. 13, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-01-22 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords